Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

InSilicoPlacenta

Financiado

Cerrado

Image-Based In Silico Modelling of Feto-Placental Vasculature

The placenta nourishes the fetus and removes its waste products in pregnancy. Fundamental to its function is the healthy development of an extensively branched tree-like structure known as the vascular tree. In pathological pregna... ver más

09/07/2025

UCY

164K€

Presupuesto del proyecto: 164K€

Líder del proyecto

UNIVERSITY OF CYPRUS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-03-27

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

UCY

164.33K€ | Lider

University of South Australi...

N.D. | Participante

GEHC

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

MOUSIE Multi Organ UltraSound based Inborn Evaluation 183K€ Cerrado

FGR PODS Fetal Growth Restriction Perinatal Outcome Decision Support... 2M€ Cerrado

MEASURE Models of the maternal and fetal cardiovascular systems coup... 188K€ Cerrado

PlaEndo The Remote Control of Maternal Metabolism by the Placenta 195K€ Cerrado

iPLACENTA Innovation in modelling Placenta for Maternal and Fetal Heal... 4M€ Cerrado

Pregnolia A simple reliable and safe diagnostic device for preterm bi... 71K€ Cerrado

Duración del proyecto: 27 meses Fecha Inicio: 2023-03-27
Fecha Fin: 2025-07-09

Líder del proyecto

UNIVERSITY OF CYPRUS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 164K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The placenta nourishes the fetus and removes its waste products in pregnancy. Fundamental to its function is the healthy development of an extensively branched tree-like structure known as the vascular tree. In pathological pregnancies, abnormalities have been found in placental structure and function. Impaired uteroplacental blood flow can lead to pregnancy disorders such as fetal growth restriction (FGR), a condition in which the fetus does not grow physiologically. FGR has lifelong consequences for both fetus and mother, affecting 8-10% of pregnancies and contributing to 30% of stillbirths. The placenta is inaccessible to in vivo measurements due to technological and ethical constraints. Ultrasound is the most routinely used clinical imaging tool for screening the placenta; however, it is limited in spatial resolution. Placental function can be also assessed via Magnetic Resonance Imaging (MRI) which is safe during pregnancy; however, MRI models cannot measure blood flow changes in the placental vascular tree. Complementary to imaging, in silico models are increasingly used to probe complex cardiovascular problems. Attempts to model blood flow in the placental vasculature are based on oversimplified assumptions while being limited by the data they have been informed or validated against with. Here, an integrated hemodynamic model of the placental vasculature will be developed using novel ex vivo computed tomography data and computational fluid dynamics. This project will innovate by delivering a computer-based framework, InSilicoPlacenta, which will offer a comprehensive understanding of the structural and functional abnormalities with FGR. We will combine medical imaging with in silico models to infer placental tissue properties of the entire placental vasculature. The long-term impacts of the proposed framework are expected to change clinical diagnosis and management of high-risk pregnancies by reducing stillbirths and improving neonatal outcomes.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores